Skip to main content

Advertisement

Log in

Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Absract

Background

Tumor budding has been suggested to be a prognostic factor in various cancers but has never been studied in esophageal cancer.

Methods

In this study, the microscopic finding of tumor budding in esophageal squamous cell carcinoma was correlated with outcome after esophagectomy. One hundred and thirty-six patients undergoing a curative esophagectomy were assigned to either a frequent (n = 82) or rare (n = 54) group according to the microscopically observed frequency of tumor budding in the tumor.

Results

The 5-year survival rates after esophagectomy were 35.4% for the frequent group and 81.3% for the rare group. Multivariate analysis using the Cox proportional hazards model by a stepwise method identified this morphological variable as a significant independent prognostic factor.

Conclusions

Tumor budding in esophageal squamous cell carcinoma reflects the biological activity of the tumor and may be a useful prognostic indicator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232:225–32

    Article  PubMed  CAS  Google Scholar 

  2. Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol 2003; 21:4592–6

    Article  PubMed  Google Scholar 

  3. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1:1303–6

    Article  PubMed  CAS  Google Scholar 

  4. Deans GT, Heatley M, Anderson N, et al. Jass’ classification revisited. J Am Coll Surg 1994; 179:11–17

    PubMed  CAS  Google Scholar 

  5. Jass JR, Ajioka Y, Allen JP, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 1996; 28:543–8

    Article  PubMed  CAS  Google Scholar 

  6. Morodomi T, Isomoto H, Shirouzu K, et al. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989; 63:539–43

    Article  PubMed  CAS  Google Scholar 

  7. Ueno H, Murphy J, Jass JR, et al. Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002; 40:127–32

    Article  PubMed  CAS  Google Scholar 

  8. Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol 2003; 83:42–7

    Article  PubMed  Google Scholar 

  9. Roh MS, Lee JI, Choi PJ. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 2004; 17:333–7

    Article  PubMed  CAS  Google Scholar 

  10. Diseases Jsfe. Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: part 2. Esophagus 2004; 1:107–25

    Google Scholar 

  11. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 1993; 36:627–35

    Article  PubMed  CAS  Google Scholar 

  12. Jass JR, Barker M, Fraser L, et al. APC mutation and tumour budding in colorectal cancer. J Clin Pathol 2003; 56:69–73

    Article  PubMed  CAS  Google Scholar 

  13. Ueno H, Price AB, Wilkinson KH, et al. A new prognostic staging system for rectal cancer. Ann Surg 2004; 240:832–9

    Article  PubMed  Google Scholar 

  14. Lieberman MD, Shriver CD, Bleckner S, et al. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg 1995; 109:130–8; discussion 139

    Article  PubMed  CAS  Google Scholar 

  15. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234:360–7; discussion 368–9

    Article  PubMed  CAS  Google Scholar 

  16. Theunissen PH, Borchard F, Poortvliet DC. Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion. Br J Surg 1991; 78:930–2

    Article  PubMed  CAS  Google Scholar 

  17. Edwards JM, Hillier VF, Lawson RA, et al. Squamous carcinoma of the oesophagus: histological criteria and their prognostic significance. Br J Cancer 1989; 59:429–33

    PubMed  CAS  Google Scholar 

  18. Zafirellis K, Dolan K, Fountoulakis A, et al. Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus 2002; 15:155–9

    Article  PubMed  CAS  Google Scholar 

  19. Ide H, Nakamura T, Hayashi K, et al. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 1994; 18:321–30

    Article  PubMed  CAS  Google Scholar 

  20. Takubo K, Sasajima K, Yamashita K, et al. Prognostic significance of intramural metastasis in patients with esophageal carcinoma. Cancer 1990; 65:1816–9

    Article  PubMed  CAS  Google Scholar 

  21. Dexter SP, Sue-Ling H, McMahon MJ, et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001; 48:667–70

    Article  PubMed  CAS  Google Scholar 

  22. Sugimachi K, Matsuoka H, Ohno S, et al. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. Br J Surg 1988; 75:1115–8

    Article  PubMed  CAS  Google Scholar 

  23. Diseases Jsfe. Guideline for diagnosis and treatment of esophageal cancer. 2007; 10–11

  24. Shimizu Y, Tsukagoshi H, Fujita M, et al. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 2002; 56:387–90

    Article  PubMed  Google Scholar 

  25. Ono M, Sakamoto M, Ino Y, et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer 1996; 78:1179–86

    Article  PubMed  CAS  Google Scholar 

  26. Gabbert H, Wagner R, Moll R, et al. Tumor dedifferentiation: an important step in tumor invasion. Clin Exp Metastasis 1985; 3:257–79

    Article  PubMed  CAS  Google Scholar 

  27. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007; 50:151–62

    Article  PubMed  CAS  Google Scholar 

  28. Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005; 168:633–42

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahiko Koike MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koike, M., Kodera, Y., Itoh, Y. et al. Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor. Ann Surg Oncol 15, 1977–1982 (2008). https://doi.org/10.1245/s10434-008-9901-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-9901-6

Keywords

Navigation